NCT00238147 Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00236899 Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC Status COMPLETED Phase PHASE3
NCT00227721 Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00227708 Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00227669 Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma Status COMPLETED Phase PHASE2
NCT00226239 Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00225420 Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00217672 Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00217581 Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00217568 Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer Status COMPLETED Phase PHASE2
NCT00217529 Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00216138 Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck Status TERMINATED Phase PHASE2
NCT00216125 Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00216112 Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00216008 Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. Status TERMINATED Phase PHASE2
NCT00215930 The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00215709 Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT00214058 Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00209092 Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT00203502 Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2